Mitsubishi Heavy Industries
7011
Mitsubishi
8058
Tokyo Electric Power
9501
4
Nippon Telegraph & Telephone
9432
5
Honda Motor
7267
JP Stock MarketDetailed Quotes
4888 Stella Pharma
- 406
- -3-0.73%
20min DelayTrading Mar 18 12:38 JST
13.82BMarket Cap-16.46P/E (Static)
414High406Low147.80KVolume410Open409Pre Close60.61MTurnover60252wk High0.74%Turnover Ratio34.03MShares26052wk Low-22.92EPS TTM8.08BFloat Cap1070Historical HighLossP/E (Static)19.91MShs Float229Historical Low-24.66EPS LYR1.96%Amplitude--Dividend TTM4.49P/B100Lot Size--Div YieldTTM
About Stella Pharma Company
Stella Pharma Corp is a therapeutic drug research and development company. It is focused on the development of boron compounds, particularly used in boron neutron capture therapy (BNCT). The BNCT is a form of cancer radiation therapy for destroying cancer cells.
Company Profile
Symbol4888
Company NameStella Pharma
Founded2007-06-01
MarketTSE Growth
Fiscal Year Ends03-31
Address3-2-7 Korai-bashi Chuo-ku, Osaka Prefecture
Zip Code541-0043
Phone06-4707-1516
Websitewww.stella-pharma.co.jp
Company Executives
- Name
- Position
- Salary
- Koki Uehara
- Representative Director and President
- --
- Wako Yabu
- Director
- --
- Toshimitsu Hayashi
- Director
- --
- Takahiro Kido
- Director
- --
- Kohei Tsujii
- Independent Director
- --
- Takashi Fukuchi
- Independent Director
- --
- Masaya Oonishi
- Independent Director
- --